1 / 5

Schizophrenia Drugs Market Movements by Trend Analysis, Growth Status, Revenue Expectation to 2026 | Research Report by

The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune Business Insights in a report, titled u201cSchizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026.u201d The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecast period.<br><br>Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/schizophrenia-drugs-market-101531<br>

NitaSonwane
Download Presentation

Schizophrenia Drugs Market Movements by Trend Analysis, Growth Status, Revenue Expectation to 2026 | Research Report by

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026 Buy Now Sample PDF Get Discount Published Date: April 2019 Report Format: PDF Region: Global Base Year: 2018 Fortune Business Insights Pvt Ltd.

  2. Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026 Report Highlights: The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune Business Insights in a report, titled “Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026.” The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecast period. The report published by Fortune Business Insights provides an exclusive overview of the schizophrenia drugs industry. The report is put together after extensive research and study by the top analysts offers key insights into the global schizophrenia drugs market to help businesses gain a competitive advantage and flourish rapidly. In-depth information on recent advancements and innovations are all present in the report. Fortune Business Insights Pvt Ltd.

  3. Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026 Rising Awareness About Mental Disorders Will Boost Growth According to Fortune Business Insights, the increasing cases of mental disorders such as schizophrenia will uplift the global schizophrenia drugs market shares. The surge in medical interventions for the treatment of major mental disorders will enable growth in the global schizophrenia drugs market during the forecast period. Furthermore, the rising emphasis on mental illness and mental health in emerging nations will boost the global schizophrenia drugs market revenue during the forecast period. Launch Of REXULTI Tablets Will Propel Growth Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company headquartered in Tokyo launched REXULTI Tablets (chemical name is brexpiprazole) in 1 mg and 2 mg tablets for the treatment of schizophrenia in patients. Based on the efficacy of REXULTI in the treatment of schizophrenia, it is included in the Japanese National Health Insurance Drug Price List. The launch of REXULTI® Tablets will favor growth to the global schizophrenia drugs market owing to the presence of a novel compound in the tablets. REXULTI Tablets will be marketed to healthcare institutions across Japan to treat patients with mental disorders. Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/schizophrenia-drugs-market-101531 Fortune Business Insights Pvt Ltd.

  4. Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026 • Furthermore, according to the report published by Fortune Business Insights on the basis of treatment outlook the global schizophrenia drugs market is segmented into oral and injectable. Injectedbale based treatment is predicted to generate maximum revenue owing to the prevention of relapses and also the irreparable cognitive and neurological damages to the patients. • Top Players Mentioned: • Fortune Business Insights profiles a few of the companies operating in the global Schizophrenia Drugs Market • H. Lundbeck A/S • Otsuka Pharmaceutical Co., Ltd. • Janssen Pharmaceuticals, Inc. • Eli Lilly and Company • AstraZeneca • ALLERGAN • Vanda Pharmaceuticals Inc.  • Sumitomo Dainippon Pharma Co., Ltd. Fortune Business Insights Pvt Ltd.

  5. Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026 About Us: Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.  Phone: US: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights Pvt Ltd.

More Related